InvestorsHub Logo
Followers 2543
Posts 250731
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Monday, 01/23/2017 12:08:15 AM

Monday, January 23, 2017 12:08:15 AM

Post# of 9479
$PMCB PharmaCyte Biotech is meeting with the U.S. FDA today to discuss our upcoming clinical trial in #PancreaticCancer - This meeting with the FDA's Center for Biologics Evaluation and Research (CBER) marks the culmination of years of hard work by the entire team of oncologists, clinicians, doctors and researchers that surrounds our pancreatic cancer therapy.

A special thanks to our partners at Austrianova for this amazing technology and pancreatic cancer therapy and for your dedication and hard work, and to our many dedicated shareholders who have helped to make this day possible - your patience is sincerely appreciated! We look forward to sharing the news from today's meeting with the public very soon.



Go $PMCB

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.